|
|
||||||||
None of a total of 2,030 Middle Eastern nationals tested was positive to histoplasmin or coccidioidin.
1 Portion of a study on the epidemiology of zoonotic diseases in the Middle East supported by a grant from Pfizer International. The histoplasmin was furnished through the courtesy of Parke, Davis and Company and Eli Lilly and Company; the coccidioidin through the courtesy of Cutter Laboratories. We are grateful to Dr. Charles Nucho, Hamlin Sanatorium; Dr. Nicolas Naasan, Dahr el Bashik Sanatorium; Dr. Papken Mugrditchian, Asounieh Sanatorium; Dr. Elias Khoury, Bhannes Sanatorium; and Dr. Antranig Manougian, Asfourieh Mental Hospital, for their coperation, and to John Himo for his technical assistance.
This article has been cited by other articles:
![]() |
H. A. REIMANN Infectious Diseases: Annual Review of Significant Publications Arch Intern Med, July 1, 1959; 104(1): 108 - 151. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |